Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer (Q28181638)
scientific article (publication date: February 2003)
Language:
Current Data About Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer
(P31) (Q13442814)

(P304) 44-8

(P407) (Q1860)

(P433) 1

(P478) 26

(P577) +2003-02-00T00:00:00Z

(P921) (Q42824440)

(Q188874)
(P887)

(Q79460)
(P887)

(Q108566365)
(P887)

(Q25493920)
(P887)

(Q422248)
(P887)

(P1433) (Q15759087)

(P1476) "Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer" (language: en)

(P2093) R-D Hofheinz
(P1545) 1

S-E al-Batran
(P1545) 2

F Hartmann
(P1545) 3

G Hartung
(P1545) 4

D Jäger
(P1545) 5

C Renner
(P1545) 6

P Tanswell
(P1545) 7

U Kunz
(P1545) 8

A Amelsberg
(P1545) 9

H Kuthan
(P1545) 10

G Stehle
(P1545) 11

other details
description scientific article (publication date: February 2003)

External Links
(P356) 10.1159/000069863
(P698) 12624517